PURPOSE OF REVIEW: To review the current status of advanced imaging techniques in identification of organ-confined @entity263 with a focus on their impact on @entity1 management. RECENT FINDINGS: Transrectal ultrasound suffers from poor accuracy despite significant technical improvements. Generally used to distinguish @entity5 with extraprostatic spread, MRI is now focusing on @entity263 identification. At 1.5T, the most recent high-resolution pelvic phased-array coils provide excellent imaging of the whole gland, including this challenging anterior part. Improvements in accuracy for @entity5 detection and volume estimation result from dynamic contrast-enhanced and diffusion-weighted imaging sequences. Histological correlations showed high sensitivity/specificity for significant @entity5 . 3T MRI scanners will improve these results. Most of the recent PET/computed tomography imaging studies use @entity1877 derivatives ( @entity25249 and @entity9242 ). Their results are promising but insufficient to be currently recommended in routine practice. SUMMARY: Considerable advances have been made in the identification of organ-confined @entity263 with multiparametric MRI. Only prebiopsy MRI can provide best quality of @entity5 assessment and allows for targeting biopsies. It is hoped that advances in 3T MRI as well as in radiotracers for PET/computed tomography will further improve diagnosis, treatment selection, planning and outcomes.

Imaging of organ-confined XXXX : functional ultrasound, MRI and PET/computed tomography.

@entity1 :: ('9606', 'Species') :: ['patient'] @entity263 :: ('MESH:D011471', 'Disease') :: ['intraprostatic prostate cancer', 'prostate cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['volume cancers', 'cancers', 'cancer'] @entity25249 :: ('CHEBI:72322', 'Chemical') :: ['(11)C-choline'] @entity9242 :: ('MESH:C514960', 'Chemical') :: ['(18)F-fluorocholine'] @entity1877 :: ('MESH:D002794', 'Chemical') :: ['choline']
@entity263 :: (MESH:D011471,Disease) :: ['prostate cancer']
